Why Arrowhead Pharmaceuticals (NASDAQ: ARWR) Skyrocketed Today?
Shares of Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) traded up 40.33% on Wednesday after it revealed the data on the drug to treat liver disease. Arrowhead has shared the positive interim 24-week liver biopsy results in four volunteers of AROAAT2002. AROAAT2002 is the open-label phase 2 clinical study of ARO-AAT. ARO-AAT is the investigational drug that […]
Why Arrowhead Pharmaceuticals (NASDAQ: ARWR) Skyrocketed Today? Read More »